Detected
ONCONasdaq Trader
Onconetix, Inc. sets 1-for-10 reverse split for Thursday, May 21, 2026
Listing RiskbearishImpact65
ONCO Price
Stored market data$0.87+$0.08 (+9.78%)
Why It Matters
The split reduces share count and tradable float by ~10x, raising per-share price while likely reducing liquidity and affecting fractional holders.
Existing holders will receive one post-split share for every ten pre-split shares, with fractional-share treatment likely resulting in cash payments.
Score65
Score Rationale
bearishReverse split materially changes share count, per-share price, and liquidity risk.
Bullish
- Higher per-share price may help meet listing thresholds.
- Cleaner share price could attract some institutional interest.
Bearish
- Liquidity per share typically falls after consolidation.
- Fractional-share cash-outs can reduce small-holder ownership.
- Reverse split often signals prior low-price/listing stress.
Key Evidence
- Pre-split price around $0.12 and shares outstanding ~3.4M per market context.
What To Watch Next
- Company or transfer agent guidance on fractional-share cash payment terms.
- Any follow-up filings about listing compliance or delisting risk.
- Post-split changes in bid-ask spreads and daily volume.
AdvertisementResponsive display
AdvertisementResponsive display
Biotechnology Market Context
SectorHealthcare+0.70%
IndustryBiotechnology-1.26%